Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib

Based on data mining, an innovative big data analysis platform was utilized to discuss the treatment of cancer in chronic myeloid leukemia (CML) by dasatinib, aiming to offer help to the diagnosis and treatment of cancer. An integrated gene expression analysis system (IEAS) was firstly constructed t...

Full description

Saved in:
Bibliographic Details
Main Authors: Linlin Song, Qi Li, Hui Shi, Pengxia Zhang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Applied Bionics and Biomechanics
Online Access:http://dx.doi.org/10.1155/2022/9294634
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563529864970240
author Linlin Song
Qi Li
Hui Shi
Pengxia Zhang
author_facet Linlin Song
Qi Li
Hui Shi
Pengxia Zhang
author_sort Linlin Song
collection DOAJ
description Based on data mining, an innovative big data analysis platform was utilized to discuss the treatment of cancer in chronic myeloid leukemia (CML) by dasatinib, aiming to offer help to the diagnosis and treatment of cancer. An integrated gene expression analysis system (IEAS) was firstly constructed to automatically classify data in the online human Mendelian genetic database using clustering algorithms. At the same time, the gene expression profile was analyzed by principal component analysis (PCA) in the analysis system. In addition, the efficacy of dasatinib in the treatment of patients with advanced CML was then retrospectively analyzed. The results showed that the IEAS system could incorporate the gene expression analysis vectors it contained by JAVA-related technologies, and the generated clustering genes showed similar functions. The clustering algorithm could homogenize data and generate visual clustering heat maps. The analysis results of major elements were diverse under different experimental conditions. The characteristic value of the first major element was the largest. Messenger ribonucleic acid (mRNA) datasets of CML patients were selected from cancer genomic map, including 120 samples and 20,614 mRNA in total. In micro-RNA (miRNA) datasets, there were 202 samples including 1,406 miRNAs. Data were screened by miRNA–mRNA regulation template, and 20 differentially expressed mRNAs were obtained. In conclusion, the proposed IEAS system could mine and analyze the gene expression data. Dasatinib showed good efficacy in the treatment of patients with advanced CML. Besides, it could improve visual queries, and data mining had a broad application prospect in clinical application. Dasatinib was considered to be a good option for patients with advanced CML.
format Article
id doaj-art-e70187a9e16740e0b2530eea007e733b
institution Kabale University
issn 1754-2103
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Applied Bionics and Biomechanics
spelling doaj-art-e70187a9e16740e0b2530eea007e733b2025-02-03T01:19:58ZengWileyApplied Bionics and Biomechanics1754-21032022-01-01202210.1155/2022/9294634Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based DasatinibLinlin Song0Qi Li1Hui Shi2Pengxia Zhang3School of Basic MedicineDepartment of BiochemistryDepartment of PharmacySchool of Basic MedicineBased on data mining, an innovative big data analysis platform was utilized to discuss the treatment of cancer in chronic myeloid leukemia (CML) by dasatinib, aiming to offer help to the diagnosis and treatment of cancer. An integrated gene expression analysis system (IEAS) was firstly constructed to automatically classify data in the online human Mendelian genetic database using clustering algorithms. At the same time, the gene expression profile was analyzed by principal component analysis (PCA) in the analysis system. In addition, the efficacy of dasatinib in the treatment of patients with advanced CML was then retrospectively analyzed. The results showed that the IEAS system could incorporate the gene expression analysis vectors it contained by JAVA-related technologies, and the generated clustering genes showed similar functions. The clustering algorithm could homogenize data and generate visual clustering heat maps. The analysis results of major elements were diverse under different experimental conditions. The characteristic value of the first major element was the largest. Messenger ribonucleic acid (mRNA) datasets of CML patients were selected from cancer genomic map, including 120 samples and 20,614 mRNA in total. In micro-RNA (miRNA) datasets, there were 202 samples including 1,406 miRNAs. Data were screened by miRNA–mRNA regulation template, and 20 differentially expressed mRNAs were obtained. In conclusion, the proposed IEAS system could mine and analyze the gene expression data. Dasatinib showed good efficacy in the treatment of patients with advanced CML. Besides, it could improve visual queries, and data mining had a broad application prospect in clinical application. Dasatinib was considered to be a good option for patients with advanced CML.http://dx.doi.org/10.1155/2022/9294634
spellingShingle Linlin Song
Qi Li
Hui Shi
Pengxia Zhang
Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
Applied Bionics and Biomechanics
title Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
title_full Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
title_fullStr Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
title_full_unstemmed Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
title_short Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
title_sort treatment of cancer gene changes in chronic myeloid leukemia by big data analysis platform based dasatinib
url http://dx.doi.org/10.1155/2022/9294634
work_keys_str_mv AT linlinsong treatmentofcancergenechangesinchronicmyeloidleukemiabybigdataanalysisplatformbaseddasatinib
AT qili treatmentofcancergenechangesinchronicmyeloidleukemiabybigdataanalysisplatformbaseddasatinib
AT huishi treatmentofcancergenechangesinchronicmyeloidleukemiabybigdataanalysisplatformbaseddasatinib
AT pengxiazhang treatmentofcancergenechangesinchronicmyeloidleukemiabybigdataanalysisplatformbaseddasatinib